These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 26934336)
21. Netrin-4 as a biomarker promotes cell proliferation and invasion in gastric cancer. Lv B; Song C; Wu L; Zhang Q; Hou D; Chen P; Yu S; Wang Z; Chu Y; Zhang J; Yang D; Liu J Oncotarget; 2015; 6(12):9794-806. PubMed ID: 25909166 [TBL] [Abstract][Full Text] [Related]
22. A proteomics based approach for the identification of gastric cancer related markers. Sheikh IA; Mirza Z; Ali A; Aliev G; Ashraf GM Curr Pharm Des; 2016; 22(7):804-11. PubMed ID: 26648471 [TBL] [Abstract][Full Text] [Related]
23. MicroRNAs as diagnostic biomarkers in gastric cancer. Yin Y; Li J; Chen S; Zhou T; Si J Int J Mol Sci; 2012 Oct; 13(10):12544-55. PubMed ID: 23202912 [TBL] [Abstract][Full Text] [Related]
24. Serum protein and genetic tumor markers of gastric carcinoma. He CZ; Zhang KH Asian Pac J Cancer Prev; 2013; 14(6):3437-42. PubMed ID: 23886124 [TBL] [Abstract][Full Text] [Related]
25. Hypermethylation in gastric cancer. Li Y; Liang J; Hou P Clin Chim Acta; 2015 Aug; 448():124-32. PubMed ID: 26148722 [TBL] [Abstract][Full Text] [Related]
26. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Wu CH; Lin SR; Yu FJ; Wu DC; Pan YS; Hsieh JS; Huang SY; Wang JY Int J Cancer; 2006 Jul; 119(2):373-9. PubMed ID: 16477642 [TBL] [Abstract][Full Text] [Related]
27. Tumor-associated autoantibody signature for the early detection of gastric cancer. Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876 [TBL] [Abstract][Full Text] [Related]
28. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer. Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges. Yang Z; Guo X; Li G; Shi Y; Li L Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks. Ge X; Wang H; Zeng H; Jin X; Sujie A; Xu C; Liu Y; Huang J; Ji Y; Tan Y; Liu T; Hou Y; Qin J; Sun Y; Qin X Hum Pathol; 2015 Jun; 46(6):850-7. PubMed ID: 25863425 [TBL] [Abstract][Full Text] [Related]
31. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Lim JB; Chung HW Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618 [TBL] [Abstract][Full Text] [Related]
32. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716 [TBL] [Abstract][Full Text] [Related]
33. Implementation of gastric cancer screening - the global experience. Leja M; You W; Camargo MC; Saito H Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1093-106. PubMed ID: 25439074 [TBL] [Abstract][Full Text] [Related]
34. Faecal calprotectin as a marker for oesophago-gastric cancer. Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128 [TBL] [Abstract][Full Text] [Related]
35. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications. Pawluczuk E; Łukaszewicz-Zając M; Mroczko B Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840 [TBL] [Abstract][Full Text] [Related]
36. Discovery of biomarkers for gastric cancer: a proteomics approach. Lin LL; Huang HC; Juan HF J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886 [TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody MG7 as a screening tool for gastric cancer. Chen Z; Hong L; Liu L; Peng D; Li Q; Jin B; Qiao T; Wu K; Fan D Hybridoma (Larchmt); 2010 Feb; 29(1):27-30. PubMed ID: 20199148 [TBL] [Abstract][Full Text] [Related]
39. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling. Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162 [TBL] [Abstract][Full Text] [Related]
40. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]